This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Johnson, L. L. Articles by Sayles, P. C. Search for Related Content PubMed PubMed Citation Articles by Johnson, L. L. Articles by Sayles, P. C.

 Previous Article  |  Next Article 

Infect. Immun., 06 1996, 1998-2003, Vol 64, No. 6
Copyright © 1996, American Society for Microbiology

CR3-dependent resistance to acute Toxoplasma gondii infection in mice

LL Johnson, GW Gibson and PC Sayles
Trudeau Institute, Inc., Saranac Lake, New York 12983, USA.

Studies were performed to determine whether resistance to acute Toxoplasma gondii infection in mice depends on a mechanism involving CR3, the type 3 complement receptor. Nineteen of 22 mice (86%) given multiple injections of the anti-CR3 monoclonal antibody, 5C6, prior to and after intraperitoneal inoculation of cysts of the ordinarily mildly virulent ME49 strain of T. gondii died within 8 to 12 days, whereas control antibody-treated mice survived. All (five of five) anti-CR3- treated BALB/c mice infected via the natural peroral route died within 8 days of infection. Flow cytometric analysis of cells recovered from peritoneal lavages of anti-CR3-treated T. gondii-infected mice revealed that the percentage of Thy-1+ CD4- CD8- cells was reduced to about 50% of that of control antibody-treated mice and to about 20% of the number of such cells in controls. The numbers of macrophages, polymorphonuclear leukocytes, and lymphocytes recovered from the peritoneal cavities of T. gondii-infected mice were all reduced in anti- CR3-treated mice to about 40% of those of controls. In addition, anti- CR3-treated mice had less than 25% of the induced NK cell activity of the controls, and gamma interferon was reduced to undetectable levels. Thus, the rapid death of anti-CR3-treated mice was probably caused by impaired preimmune defenses. Histological examination of anti-CR3- treated T. gondii-infected mice revealed extensive liver pathology compared with that of infected mice given a control antibody or uninfected mice given anti-CR3. The inflammation, degeneration, and necrosis in most of the anti-CR3-treated mice were severe enough to account for the observed mortalities.

This article has been cited by other articles:

• Jha, P., Sohn, J.-H., Xu, Q., Nishihori, H., Wang, Y., Nishihori, S., Manickam, B., Kaplan, H. J., Bora, P. S., Bora, N. S. (2006). The complement system plays a critical role in the development of experimental autoimmune anterior uveitis.. IOVS 47: 1030-1038 [Abstract] [Full Text]  
• Johnson, L. L., Sayles, P. C. (1997). Interleukin-12, Dendritic Cells, and the Initiation of Host-protective Mechanisms against Toxoplasma gondii. JEM 186: 1799-1802 [Full Text]  
• Marth, T., Kelsall, B. L. (1997). Regulation of Interleukin-12 by Complement Receptor 3 Signaling. JEM 185: 1987-1995 [Abstract] [Full Text]